CME Group (NASDAQ:CME) Price Target Raised to $275.00 at The Goldman Sachs Group

CME Group (NASDAQ:CME) had its price objective boosted by The Goldman Sachs Group from $266.00 to $275.00 in a research note issued to investors on Monday,MarketScreener reports. They currently have a sell rating on the financial services provider’s stock.

Other equities analysts also recently issued reports about the stock. TD Cowen boosted their target price on shares of CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. UBS Group reiterated a “neutral” rating and issued a $310.00 price target on shares of CME Group in a research note on Friday, February 6th. Morgan Stanley lifted their price objective on shares of CME Group from $319.00 to $340.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research note on Thursday, February 5th. Finally, Royal Bank Of Canada upped their target price on shares of CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a report on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $304.06.

CME Group Stock Up 0.8%

CME stock opened at $313.83 on Monday. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. The business has a 50 day moving average price of $296.58 and a two-hundred day moving average price of $279.39. The company has a market cap of $113.17 billion, a price-to-earnings ratio of 28.12, a P/E/G ratio of 3.36 and a beta of 0.24. CME Group has a twelve month low of $248.53 and a twelve month high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.52 EPS. Analysts anticipate that CME Group will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, March 10th. This represents a $5.20 annualized dividend and a yield of 1.7%. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is 46.59%.

Insider Activity at CME Group

In related news, Director William R. Shepard bought 251 shares of the business’s stock in a transaction dated Tuesday, December 30th. The stock was bought at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the purchase, the director owned 258,710 shares in the company, valued at $72,017,102.70. This represents a 0.10% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Dennis Suskind sold 748 shares of CME Group stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $300.00, for a total transaction of $224,400.00. Following the sale, the director directly owned 2,699 shares of the company’s stock, valued at $809,700. The trade was a 21.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 5,248 shares of company stock valued at $1,616,700. 0.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Amundi raised its position in shares of CME Group by 24.0% in the second quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after buying an additional 385,225 shares in the last quarter. Truist Financial Corp boosted its stake in shares of CME Group by 8.9% in the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock valued at $19,106,000 after buying an additional 5,773 shares during the period. Alley Investment Management Company LLC grew its position in CME Group by 86.0% during the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after buying an additional 13,512 shares in the last quarter. Elevate Capital Advisors LLC increased its stake in CME Group by 85.2% during the 3rd quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock worth $2,302,000 after acquiring an additional 3,919 shares during the period. Finally, Victory Financial Group LLC increased its stake in CME Group by 310.2% during the 2nd quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after acquiring an additional 2,302 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.